SEGLUROMET 2.5 mg/1 (Ertugliflozin and Metformin Hydrochloride TABLET, FILM COATED) 2.5 mg/1

Segluromet 2.5 mg/1 combines ertugliflozin and metformin hydrochloride for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan.

Strength

2.5 mg/1

Pack Size

180 TABLET, FILM COATED in 1 BOTTLE (0006-5369-06)

Manufacturer / TM Owner

Merck Sharp & Dohme LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Segluromet 2.5 mg/1 is used to help manage type 2 diabetes in adults. It works by improving blood sugar levels, often alongside diet and exercise. This combination medication is designed for those who need additional glycemic control beyond metformin alone.

Side Effects

Common effects of Segluromet 2.5 mg/1 may include symptoms like urinary tract infections, genital mycotic infections, and gastrointestinal discomfort. Individual responses can vary, and not everyone will experience these effects.

Precautions & Warnings

Handle Segluromet 2.5 mg/1 with care, especially if you have kidney issues or are at risk for dehydration. Always follow your healthcare provider's guidance regarding its use and monitor for any adverse reactions.

Avoid Interactions

Segluromet 2.5 mg/1 may interact with certain medications, including diuretics, insulin, and other diabetes treatments. It's important to discuss all current medications with your healthcare provider to avoid potential interactions.

Frequently Asked Questions

Segluromet 2.5 mg/1 is used to help manage type 2 diabetes by improving blood sugar levels.

Segluromet 2.5 mg/1 is taken orally, typically as directed by a healthcare provider.

Common side effects may include urinary tract infections, genital mycotic infections, and gastrointestinal discomfort.

Segluromet 2.5 mg/1 may interact with other medications, so it's important to consult a healthcare provider before combining treatments.

Individuals with severe kidney problems or those at risk for dehydration should exercise caution with Segluromet 2.5 mg/1.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.